Need to include ASMD as a notified condition in the National Policy for rare diseases
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
GenWorks Health Introduces Braster Pro for breast screening & EVA for cervical screening in rural areas & communities
Lupin enters into BTA with Lupin Manufacturing Solutions
The composition of ORAAL is protected by a granted patent in India until November 2033
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated